Procalcitonin is an independent predictor for coronary atherosclerotic burden in patients with stable coronary artery disease

Kurtul A., Elcik D.

INTERNATIONAL JOURNAL OF CARDIOLOGY, vol.236, pp.61-64, 2017 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 236
  • Publication Date: 2017
  • Doi Number: 10.1016/j.ijcard.2017.02.061
  • Journal Name: INTERNATIONAL JOURNAL OF CARDIOLOGY
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.61-64
  • Keywords: Procalcitonin, Coronary atherosclerotic burden, Stable coronary artery disease, SYNTAX SCORE, MYOCARDIAL-INFARCTION, INTERVENTION, INFLAMMATION, MONOCYTES, ASSOCIATION, EXPRESSION, CYTOKINES
  • Erciyes University Affiliated: No

Abstract

Objectives: Higher coronary atherosclerotic burden has been associated with increased cardiovascular events including mortality. The SYNTAX score (SXs) reflects coronary atherosclerotic burden. Given the body of evidence implicating inflammation in atherosclerotic process, we hypothesized that procalcitonin (PCT) as an inflammatory marker may be related to coronary atherosclerotic burden. Thus, we aimed to investigate the relationship between serum PCT levels and SXs in patients with stable CAD.